[Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex
F
F
Service d'oncologie, Hôpital Jules Courmot, Lyon.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D015201:Meta-Analysis as Topic; D009367:Neoplasm Staging; D011182:Postoperative Care; D011300:Preoperative Care; D011879:Radiotherapy Dosage; D013997:Time Factors
D000970:Antineoplastic Agents
Prise en charge thérapeutique des cancers bronchiques non à petites cellules (CBNPC) de stades III A.